Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05989620 · ClinicalTrials.gov registry record
Long-Term Development of Muscular Dystrophy Outcome Assessments
A clinical trial of LGMD2A and LGMD2C, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05989620 is a study of LGMD2A and LGMD2C that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05989620, a study of LGMD2A and LGMD2C, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2029-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05989620
The ClinicalTrials.gov registry entry for NCT05989620 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with LGMD2A appearing as the primary indexed condition, and to 0 interventions.
NCT05989620 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05989620 about?
NCT05989620 is a clinical study titled "Long-Term Development of Muscular Dystrophy Outcome Assessments". This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).
What is the current status of trial NCT05989620?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-10-18. Estimated completion is 2029-05-01.
What conditions does trial NCT05989620 study?
This clinical trial studies the following conditions: LGMD2A, LGMD2C, LGMD1B, LGMD1C, LGMD1D.
Who is sponsoring clinical trial NCT05989620?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05989620 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for LGMD2A
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.